抗癌CAR - T细胞在难以治疗的肿瘤上显示出有希望的效果

IF 48.5 1区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

Nature Pub Date : 2025-06-02 DOI:10.1038/d41586-025-01722-8

引用次数: 0

摘要

在中国进行的试验是这种免疫疗法首次对实体肿瘤起作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Cancer-fighting CAR T cells show promising results for hard-to-treat tumours

Trial in China is one of the first times the immune therapy has worked against solid tumours.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature 综合性期刊-综合性期刊

CiteScore

90.00

自引率

1.20%

发文量

3652

审稿时长

3 months

期刊介绍： Nature is a prestigious international journal that publishes peer-reviewed research in various scientific and technological fields. The selection of articles is based on criteria such as originality, importance, interdisciplinary relevance, timeliness, accessibility, elegance, and surprising conclusions. In addition to showcasing significant scientific advances, Nature delivers rapid, authoritative, insightful news, and interpretation of current and upcoming trends impacting science, scientists, and the broader public. The journal serves a dual purpose: firstly, to promptly share noteworthy scientific advances and foster discussions among scientists, and secondly, to ensure the swift dissemination of scientific results globally, emphasizing their significance for knowledge, culture, and daily life.